Suppr超能文献

钆塞酸二钠增强 MRI 肝胆期图像肝内门脉周围高信号:各种肝胆疾病的影像学表现及发生率。

Intrahepatic periportal high intensity on hepatobiliary phase images of Gd-EOB-DTPA-enhanced MRI: imaging findings and prevalence in various hepatobiliary diseases.

机构信息

Department of Quantum Medical Technology, Kanazawa University School of Medicine, 5-11-80 Kodatsuno, Kanazawa 920-0942, Japan.

出版信息

Jpn J Radiol. 2013 Jan;31(1):9-15. doi: 10.1007/s11604-012-0136-x. Epub 2012 Oct 3.

Abstract

PURPOSE

To reveal the incidence and degree of intrahepatic periportal high intensity (PHI) on hepatobiliary phase images of Gd-EOB-DTPA-enhanced MRI (EOB-MRI) in patients with or without various hepatobiliary diseases.

MATERIALS AND METHODS

Patients with normal liver (N = 256) and those with hepatic disorder (N = 857) who underwent EOB-MRI were the subjects in this study. Incidence of PHI was evaluated among the patients with normal liver and those with hepatic disorder. Degree of PHI was categorized into four grades and compared among the various hepatic diseases. Enhancement ratios (ER) of the PHI area, background liver with PHI, and background liver in control cases without PHI were evaluated.

RESULTS

PHI was observed in 2.7 % of the patients with hepatic disorder. No PHI was observed in the patients with normal liver. The incidence rates of PHI among various hepatobiliary diseases were as follows; liver cirrhosis 3.1 %, chronic hepatitis 1.0 %, primary biliary cirrhosis 12.5 %, idiopathic portal hypertension 33.3 %. The ER of the PHI area and background liver were 3.92 and 2.48 (p = 0.0002). There were no significant differences between the ER of the PHI area and the ER of background liver in the noncirrhotic control without PHI.

CONCLUSION

In 2.7 % of the patients with a hepatic disorder, the periportal area was saved from decrease of EOB uptake and it showed PHI.

摘要

目的

揭示 Gd-EOB-DTPA 增强 MRI(EOB-MRI)肝胆期图像上肝内门脉周围高信号(PHI)的发生率和程度,包括有无各种肝胆疾病的患者。

材料与方法

本研究纳入了 256 例正常肝脏患者和 857 例肝脏疾病患者。评估正常肝脏患者和肝脏疾病患者中 PHI 的发生率。将 PHI 程度分为四级,并比较各种肝脏疾病之间的差异。评估 PHI 区域、有 PHI 的背景肝和无 PHI 的对照组背景肝的增强比(ER)。

结果

肝脏疾病患者中观察到 2.7%的 PHI。正常肝脏患者中未观察到 PHI。各种肝胆疾病中 PHI 的发生率如下:肝硬化 3.1%,慢性肝炎 1.0%,原发性胆汁性肝硬化 12.5%,特发性门静脉高压症 33.3%。PHI 区域和背景肝的 ER 分别为 3.92 和 2.48(p=0.0002)。在无 PHI 的非肝硬化对照组中,PHI 区域的 ER 与背景肝的 ER 之间无显著差异。

结论

在 2.7%的肝脏疾病患者中,门脉周围区域从 EOB 摄取减少中得到保护,并显示 PHI。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验